Skip to main content
. Author manuscript; available in PMC: 2022 Jun 19.
Published in final edited form as: J Acquir Immune Defic Syndr. 2022 Jun 1;90(2):232–239. doi: 10.1097/QAI.0000000000002937

Figure 2. Meta-analysis of IRIS in randomized controlled trials of InSTI.

Figure 2

IRIS, immune reconstitution inflammatory syndrome; InSTI, integrase strand transfer inhibitor; DTG, dolutegravir; RAL, raltegravir; EVG, elvitegravir; M-H, Mantel-Haenszel; RR, risk ratio; CI, confidence interval.